Skip to content

Heart Rate Changes During Normal Activity, Exercise, and Seizures in Subjects With Epilepsy

Heart Rate Changes During Normal Activity, Exercise, and Seizures in Subjects With Epilepsy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01214707
Enrollment
30
Registered
2010-10-05
Start date
2010-09-30
Completion date
Unknown
Last updated
2012-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Keywords

Exercise/No active Treatment

Brief summary

Characterization of the cardiac response (ECG) preceding an epileptic seizure.

Detailed description

Characterization of the cardiac response (ECG) to physiologic events and comparison to changes in heart rate that precede an epileptic seizure.

Interventions

OTHERExercise

Exercise during EMU stay

Sponsors

Cyberonics, Inc.
Lead SponsorINDUSTRY

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patient has a clinical diagnosis of epilepsy requiring additional evaluation in an epilepsy monitoring unit (EMU). 2. Patient likely requires an EMU evaluation for a period of at least 3 days. 3. In the opinion of the Principal Investigator, the Patient is likely to have 3 - 5 seizures during the EMU stay. 4. Patient is currently taking at least one antiepileptic medication. 5. Patients must be 18 years or older and may be of either sex and of any race. 6. Patient must be in good general health, fully ambulatory, and able to complete the physical aspects of testing requirements. 7. Patient must be willing and able to complete informed consent and HIPAA authorization. 8. Patient is diagnosed with epilepsy but may also experience pseudo seizures or psychogenic seizures.

Exclusion criteria

1. Patients with severe psychiatric disease that in the investigator's judgment would prevent the patient's successful completion of the study. 2. Patients experiencing status epileptic within the last 6 months. 3. Patients with cardiovascular, respiratory, neuromuscular or gait disorders that in the investigator's judgment would cause unnecessary risk. 4. Patients prescribed drugs specifically for a cardiac or autonomic disorder that in the investigator's opinion would affect heart rate response. Drugs with secondary cardiac or autonomic actions are allowed. 5. Patients with cardiovascular arrhythmias or cardiac disease that would preclude the ability to detect intrinsic changes in heart rate due to exercise, stress, or seizure. This would include but not be limited to chronic atrial fibrillation and permanent cardiac pacemaker implantation. 6. Patients currently dependent on alcohol or narcotic drugs as defined by DSM IV-R. 7. Patients with a history of only psychogenic seizures or pseudo seizures. 8. Women who are pregnant. Women of childbearing age must take a pregnancy test.

Design outcomes

Primary

MeasureTime frameDescription
Heart Rate Changes during Normal Activity, Exercise, and Seizures in Subjects with Epilepsy3 to 5 daysCharacterization of the cardiac response (ECG) to physiologic events and comparison to changes in heart rate that precede an epileptic seizure.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026